Currently out of the existing stock ratings of Jason Mills, 28 are a HOLD (13.46%), 178 are a BUY (85.58%), 2 are a SELL (0.96%).

Jason Mills

Work Performance Price Targets & Ratings Chart

Analyst Jason Mills, carries an average stock price target met ratio of 84.21% that have a potential upside of 23.17% achieved within 313 days. Previously, Jason Mills worked at CANACCORD, TD COWEN.

Jason Mills’s has documented 447 price targets and ratings displayed on 25 stocks. The coverage was on Healthcare, Industrials sectors.

Most recent stock forecast was given on PEN, Penumbra at 20-Jan-2026.

Wall Street Analyst Jason Mills

Analyst best performing recommendations are on ELGX (ENDOLOGIX).
The best stock recommendation documented was for VAPO (VAPOTHERM) at 3/5/2020. The price target of $112 was fulfilled within 11 days with a profit of $30.8 (37.93%) receiving and performance score of 34.48.

Average potential price target upside

BSX Boston Scientific Corp EW Edwards Lifesciences Corp IRT Independence Realty Trust ISRG Intuitive Surgical LMAT LeMaitre Vascular NVRO Nevro Corp STAA STAAR Surgical Company PEN Penumbra TCMD Tactile Systems Technology LIVN LivaNova PLC VAPO Vapotherm AORT Artivion CRY CryoLife SWAV Shockwave Medical MMSI Merit Medical Systems ANGO AngioDynamics ATRC AtriCure NVCN Neovasc STIM Neuronetics TEF Telefonica SA ADR TMDX TransMedics Group ELGX Endologix CR Crane Company IRTC iRhythm Technologies SW Smurfit WestRock plc

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 30-Jul-2026

$48

$5.4 (12.68%)

$50

9 days ago
(24-Sep-2026)

18/25 (72%)

$3.32 (7.43%)

226

Buy Since 16-Jan-2026

$65

$22.4 (52.58%)

$85

12 days ago
(21-Sep-2026)

0/4 (0%)

$21.28 (48.67%)

Buy Since 25-Apr-2019

$50

$7.4 (17.37%)

$61

16 days ago
(17-Sep-2026)

21/31 (67.74%)

$6.45 (14.81%)

267

Buy Since 06-Feb-2020

$56

$13.4 (31.46%)

$60

24 days ago
(09-Sep-2026)

20/36 (55.56%)

$11.04 (24.56%)

259

Buy Since 06-Dec-2013

$56

$13.4 (31.46%)

$56

1 months 8 days ago
(25-Aug-2026)

24/38 (63.16%)

$6.14 (12.31%)

329

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?